CXCL8 and familial pancreatic carcinoma: Our prior findings reveal that activated inflammatory CAFs (iCAFs) enhance oxaliplatin resistance in pancreatic cancer through an IL-8-driven DNA damage repair pathway [15], yet the activation mechanism of IL-8 by iCAFs is still to be clarified.